
Who owns Moderna stock?
Rep. Josh Gottheimer, a Democrat of New Jersey, was the only other lawmaker who held Moderna stock. In May 2020, he sold up to $15,000 worth of his shares.
How many members of Congress own the stock?
At last count, 52 members of Congress -- 19 Democrats and 33 Republicans -- owned shares of this company. I'll tell you more about the stock in a moment. But first, I think you should understand why it's important to know that Congress owns the stock at all...
How many Moderna shares does Langer own?
Robert S. Langer owns a total of 11.5 million Moderna shares, representing 2.9% of the company's total shares outstanding. 4 Langer serves on the board of directors. He is the David H. Koch Institute Professor at the Massachusetts Institute of Technology (MIT) and has about 800 issued and pending patents.
How many Moderna shares does Stéphane Bancel own?
Stéphane Bancel owns a total of 6.4 million Moderna shares, representing 1.6% of the company's total shares outstanding. 4 Bancel currently serves as chief executive officer (CEO) and as a member of the board of directors.

How much stock does Joe Kennedy own?
His disclosure shows he’s profited from rising drug prices. Last year, he reported owning up to $2.1 million in stock in pharmaceutical and health products companies in a family trust.
Who is the former Microsoft employee?
Another former Microsoft employee, Rep. Josh Gottheimer (D-N.J.), held up to $5.2 million in Microsoft stock. Tech companies are among the most popular assets for lawmakers, with 42 members invested in Google, 37 in Amazon and 34 in Facebook as of the most recent filings.
Has the pharmaceutical lobby defeated the bill?
The pharmaceutical lobby has successfully defeated bill after bill that would limit the rising price of drugs. The industry coupled record lobbying spending with targeted campaign donations and direct appeals to President Donald Trump to ward off policy changes.
Does John F Kennedy have control over Pfizer?
Kennedy has said he has no control over the assets in his family trust. Pfizer is one of the most popular stocks in Congress, with 48 lawmakers placing their bet on the drugmaker that hikes its prices each year. Rep. Jim Sensenbrenner (R-Wis.), the second most senior congressman, reported holding between $1 million and $5 million in Pfizer stock.
Who added the provision to the defense conference report?
Senator Bill Frist added the provision to the defense conference report, approved by the House of Representatives on Sunday, after conferees had signed what they were told was the final product. Nine members of the Senate conference committee hold pharmaceutical stock.
Can a senator vote in his own interests?
No Senator should be able to vote in his own financial interests at the expense of the public," said Balber. FTCR released an analysis of Senate personal financial disclosures last week, revealing that 42 senators -- 27 Republicans and 15 Democrats -- held pharmaceutical stock worth between $8.1 and $16 million in 2004.
Did Senators with pharmaceutical holdings vote?
Four Senators with pharmaceutical holdings did not vote. The provision grants immunity to drug companies for any vaccine or product, classified by the Bush Administration as necessary to respond to a public health threat, when patients are harmed by dangerous drugs.
How many Moderna shares does OCHA own?
OCHA directly owns 7.6 million Moderna shares while Boston Biotech owns about 9.1 million shares. Additionally, Bancel's institutional holdings include 5.2 million shares issuable upon exercise of share options and approximately 0.2 million shares held by a trust for the benefit of his family.
How many Moderna shares does Stéphane Bancel own?
Stéphane Bancel owns a total of 6.4 million Moderna shares, representing 1.6% of the company's total shares outstanding. 4 Bancel currently serves as chief executive officer ( CEO) and as a member of the board of directors.
How much did Bancel raise before Moderna?
Since joining Moderna in 2011, he has led the company's expansion, partly by raising close to $2 billion through equity financing and licensing collaborations. Before Moderna, Bancel was CEO of bioMérieux SA, a French-based biotechnology company.

Congress Insider Trading Used to Be...Legal?
The Stock Act
- In light of the public outcry on the '60 Minutes' piece, the STOCK Act was passed in 2012. The STOCK Act makes it illegal for members of Congress (and other federal employees, including the President) to trade securities based on material, nonpublic information. This includes the buying or selling of securities of individual companies. The STOCK Act requires detailed financial disclo…
Congress Historical Investment Holdings
- Historically, Congress has been allowed to participate in individual stock investments with no restrictions, and were not required to disclose their holdings. The STOCK Act put an end to this, and information about Congress' investments is publicly available. Unfortunately, due to an amendment to the STOCK Act, the information is not readily available on a government website, …
10 Most Popular Stocks Owned by Congress in 2021
- Here's what Congress is currently invested in: There are a few interesting items of note in this list: 1. Pfizer has climbed back into the top 10, at the #6 spot, with almost 50 Congress members holding the stock 2. General Electric has fallen down the list, despite being the #1 holding for almost a decade 3. Apple is overwhelmingly the favorite st...
Interesting Investment Moves by Congress Since 2008
- While the STOCK Act was designed to put a halt to insider trading, there are still instances of questionable investment moves by members of Congress. Here are a few of the most recent trades by members of Congress that have come under scrutiny: Spencer Bachus (R-AL). Bachus bought put optionsthe day after a private meeting with the Fed chairman, Ben Bernanke, in Septe…
Final Thoughts
- Congress members are free to buy and sell stocks, and as you can see, they have bet heavily in the tech and healthcare sectors. With Apple as the top holding for Congress members in 2018, those bets have paid off handsomely in 2021, with Apple stock almost triple its former valuation. It also may be a bit shocking to the American public how much wealth is held by members of Co…